According to reports, three Siberian health care workers who received the so-called Sputnik V coronavirus vaccine from Russia have tested positive for the fatal error.
Altai region officials reported that the three were among 42 medical personnel who received two doses of the vaccine, which Russian health officials say is 92 percent effective, the Moscow Times reported.
According to the region’s administration, “there is no time to form until the immune system of sick doctors is exposed to the Covid-19 pathogen.” “Only that can cause a doctor’s infection.”
The vaccine’s developer has indicated that infected recipients of the inoculation have received a placebo during final clinical trials, the news outlet reports.
And the developer also said that immunity comes only after the first six weeks of the two injections, East 2 West News quoted health officials as saying.
The chief infectious physician of the region, Dr. Irina Pereladova told a local news outlet that all three workers became infected within 24 hours between the negative tests and the first shot, according to East 2 West.
But the regional branch of the health ministry later admitted that they may have contracted the disease even though they had received one or two.
A person is considered vaccinated and, accordingly, is protected from coronavirus infection just three weeks after the second vaccination, the ministry said.
According to the Moscow Times, in parallel with Moscow, officials are vaccinating a select group of healthcare workers and teachers from across the country, where it is conducting examinations with 1,000,000 volunteers, according to the Moscow Times.
In the Altai region – Russia’s 85 regions, Kovid-19 infection is the highest among 18, with a second batch of 2,000 doses of the vaccine expected early next year, the Tass report said.
Russia’s Sovereign Wealth Fund said in a statement that the Sputnik Vine vaccine was 92% effective, according to a Reuters report.
Results The results are based on data from the first 16,000 trial participants to receive both shots of the two-phase vaccine, according to the Russian Direct Investment Fund, which markets it globally.
“Based on the data, we are showing that we have a very effective vaccine.” RDIF chief Kirill Dimitriev said there was news that developers without Sputnik V would one day talk to their grandchildren.
Russia’s announcement was quickly followed by results posted Monday by Pfizer and Bioentech, which said their shots were also more than 90 percent effective.
Scientists have expressed concern about the speed at which Moscow has worked, greening the vaccine and launching a mass inoculation program before full tests to test its safety and effectiveness.
Tribute to the Soviet Union’s first orbital satellite in 1957 – when Russia recorded it – was the first country to do so for public use in August Gust, although approval came before the start of a large-scale trial in September.
.
